GeoVax Expands Immuno-Oncology Pipeline with Acquisition of Clinical-Stage Cancer Program

Go back to GeoVax Expands Immuno-Oncology Pipeline with Acquisition of Clinical-Stage Cancer Program
GeoVax Labs, Inc. (NASDAQ: GOVX) Delayed: 1.39 +0.66 (90.41%)
Previous Close $0.73    52 Week High $0.14 
Open $0.80    52 Week Low $0.05 
Day High $1.59    P/E N/A 
Day Low $0.76    EPS $-0.14 
Volume 33,602,407       

(NASDAQ: GOVXW) Delayed: 0.49 +0.22 (81.48%)
Previous Close $0.27    52 Week High
Open $0.42    52 Week Low
Day High $0.49    P/E N/A 
Day Low $0.35    EPS
Volume 11,826